Related Experiment Video
Updated: May 17, 2026
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
[Update pneumonia 2012]
1Zentrum für Infektionsmedizin und Krankenhaushygiene, Universitätsklinikum Jena, Germany. mathias.pletz@med.uni-jena.de
Abstract:
Pneumonia is an infection of the lung parenchyma and defined as combination of a novel radiological infiltrate with typical signs and symptoms. There are 3 distinguished entities of pneumonia: community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP), and pneumonia in the immunocompromised patient. The spectrum of pathogens is increasing from CAP, mostly caused by pneumococci, over HAP (additional multi-drug resistant pathogens) to pneumonia in the immunocompromised (additional opportunistic pathogens). Therefore, each entity demands a specific diagnostic and therapeutic approach. This review compares the 3 forms of pneumonia and presents a guideline based clinical approach in the context of current studies.
Insights
Pneumonia, an infection of lung tissue, presents in three forms: community-acquired, hospital-acquired, and in immunocompromised patients. Each type requires a distinct diagnostic and treatment strategy due to evolving pathogens.
Area of Science:
- Pulmonology
- Infectious Diseases
- Clinical Medicine
Context:
- Pneumonia is a significant lung infection with varied origins.
- Distinguishing between community-acquired, hospital-acquired, and immunocompromised-related pneumonia is crucial.
- Pathogen spectrum broadens from typical bacteria to multi-drug resistant and opportunistic organisms.
Purpose:
- To compare the three main entities of pneumonia: CAP, HAP, and pneumonia in immunocompromised patients.
- To present a guideline-based clinical approach for diagnosing and treating pneumonia.
- To contextualize these approaches within current scientific literature.
Summary:
- Pneumonia, defined by radiological infiltrate and clinical signs, encompasses CAP, HAP, and pneumonia in immunocompromised individuals.
- Pathogen complexity increases across these categories, necessitating tailored management.
- This review contrasts the three forms and outlines a clinical strategy.
Impact:
- Provides a clear comparison of distinct pneumonia types.
- Offers a structured clinical approach for healthcare providers.
- Highlights the importance of specific diagnostic and therapeutic strategies based on pneumonia classification.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
01:29Pneumonia II: Pathophysiology
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:29Pneumonia I: Introduction
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...